1. Flavonol 7-O-Glucoside herbacitrin Inhibits HIV-1 Replication through Simultaneous Integrase and Reverse Transcriptase Inhibition. Ay, E., A. Hunyadi, M. Mezei, J. Minarovits, and J. Hohmann. Evidence-Based Complementary and Alternative Medicine, 2019. 2019(1064793): 6pp. PMID[30853999]. PMCID[PMC6378053].
[PubMed]. HIV_03_2019.
2. PF74 Inhibits HIV-1 Integration by Altering the Composition of the Preintegration Complex.Balasubramaniam, M., J. Zhou, A. Addai, P. Martinez, J. Pandhare, C. Aiken, and C. Dash. Journal of Virology, 2019. 93(6): e01741-01718. PMID[30567984]. PMCID[PMC6401427].
[PubMed]. HIV_03_2019.
3. Synthesis and Antiviral Evaluation of 3'-Fluoro-4'-modified-5'-norcarbocyclic Nucleoside Phosphonates. Geant, P.Y., M. Kaci, J.P. Uttaro, C. Perigaud, and C. Mathe. ChemMedChem, 2019. 14(5): p. 522-526. PMID[30637958].
[PubMed]. HIV_03_2019.
4. Peptide Assembly on the Membrane Determines the HIV-1 Inhibitory Activity of Dual-targeting Fusion Inhibitor Peptides. Gomara, M.J., Y. Perez, J.P. Martinez, R. Barnadas-Rodriguez, A. Schultz, H. von Briesen, A. Peralvarez-Marin, A. Meyerhans, and I. Haro. Scientific Reports, 2019. 9(3257): 13pp. PMID[30824796]. PMCID[PMC6397244].
[PubMed]. HIV_03_2019.
5. Benzothiazol Clubbed Imidazol-4-ones as Anti-fungal, Anti-tubercular and anti-HIV-1 Agents: Their Synthesis and Molecular Docking Study. Patel, N.B., A.R. Shaikh, V.M. Patel, E.E. Lara-Ramirez, and G. Rivera. Letters in Drug Design & Discovery, 2019. 16(4): p. 382-391. ISI[000460607700002].
[WOS]. HIV_03_2019.
6. Anti-HIV-1 Integrase Potency of Methylgallate from Alchornea cordifolia Using in Vitro and in Silico Approaches. Siwe-Noundou, X., T.M. Musyoka, V. Moses, D.T. Ndinteh, D. Mnkandhla, H. Hoppe, O. Tastan Bishop, and R.W.M. Krause. Scientific Reports, 2019. 9(1): p. 4718. PMID[30886338]. PMCID[PMC6423119].
[PubMed]. HIV_03_2019.
7. A Peptide-based HIV-1 Fusion Inhibitor with Two Tail-anchors and Palmitic acid Exhibits Substantially Improved in Vitro and ex Vivo anti-HIV-1 Activity and Prolonged in Vivo Half-life. Su, S., G. Rasquinha, L. Du, Q. Wang, W. Xu, W. Li, L. Lu, and S. Jiang. Molecules, 2019. 24(6): E1134. PMID[30901967].
[PubMed]. HIV_03_2019.
8. Role of APOBEC3 Proteins in Proteasome Inhibitor-mediated Reactivation of Latent HIV-1 Viruses. Timilsina, U., D. Ghimire, S. Sharma, and R. Gaur. Journal of General Virology, 2019. 100(3): p. 523-532. PMID[30566069].
[PubMed]. HIV_03_2019.
9. QSAR and Docking Studies of Data Analogues as HIV-1 Reverse Transcriptase Inhibitors.Tong, J.B., S. Lei, P. Zhan, S.S. Qin, and Y. Wang. Letters in Drug Design & Discovery, 2019. 16(2): p. 153-159. ISI[000459738100006].
[WOS]. HIV_03_2019.
10. Targeting the Hydrophobic Channel of NNIBP: Discovery of Novel 1,2,3-Triazole-derived Diarylpyrimidines as Novel HIV-1 NNRTIs with High Potency against Wild-type and K103N Mutant Virus. Zhou, Z., T. Liu, G. Wu, D. Kang, Z. Fu, Z. Wang, E. De Clercq, C. Pannecouque, P. Zhan, and X. Liu. Organic and Biomolecular Chemistry, 2019. 17(12): p. 3202-3217. PMID[30839042].
[PubMed]. HIV_03_2019.
Patent Citations
11. Preparation of Choline Salt Forms of a Cyclopropacyclopentapyrazolylacetamide Compound HIV Capsid Inhibitor. Houston, T.L. and B. Shi. Patent. 2019. 2018-US248 2019035973: 124pp.
[Patent]. HIV_03_2019.
12. Methods and Compositions for the Antiviral Use of Synthetic Lysine Analogs and Mimetics. Murdock, F., R. Murdock, and W.P. Stewart. Patent. 2019. 2018-US46023 2019045989: 60pp.
[Patent]. HIV_03_2019.
13. Preparation of Quinoline and Naphthyridine Derivatives for Treating HIV Infection and/or Cancer. Techasakul, S., A. Makarasen, N. Reuk-Ngam, P. Khlaychan, M. Kuno, and S. Hannongbua. Patent. 2019. 2017-TH66 2019045655: 54pp.
[Patent]. HIV_03_2019.
14. High Affinity CXCR4 Selective Binding Conjugate and Method for Using the Same. Zhang, J. and L.Z. Yan. Patent. 2019. 2018-US18530 2019050564: 45pp.
[Patent]. HIV_03_2019.